Abstract
The natural history of vertically acquired HCV infection is ill defined. The aim of this study was to outline the natural course of vertical HCV infection in a cohort of untreated children, including rate of spontaneous viral clearance, frequency and features of HCV-related autoimmune disorders. Children with vertical HCV infection were prospectively followed from the first month of life with regular clinical and laboratory assessments. Statistical analysis was performed using Prism 5.0. Forty-five children (median age 12 years, interquartile range 6.9–15.5) were studied. Genotype 1 was predominant (53.3 %). Spontaneous viral clearance was achieved by 12 patients (26.7 %) and associated with genotype 3. Alanine-amino-transferase levels were increased in most children in the first 2 years of life with higher values in those who later cleared the infection. All children were asymptomatic for liver disease. Transient elastography (32 patients) showed mild or moderate fibrosis in nine and two cases, respectively. Non-organ-specific autoantibodies were detected in 24 children (53.3 %) independently of viremia; of these, one developed type-1 diabetes. Cryoglobulinemia was associated with genotype 1 infection and found in 15 subjects (33.3 %): two had low C4 levels and persistent proteinuria. Conclusions: Vertically acquired HCV infection may result in spontaneous clearance in up to 27 % of children. Resolution of infection is higher with genotype 3, usually occurs in preschool age and persists over time. Chronic infection is generally asymptomatic, although hepatomegaly and mild fibrosis may develop. Autoantibodies and cryoglobulins are frequent, whereas the associated clinical manifestations are rare.
Similar content being viewed by others
Abbreviations
- ALT:
-
Alanine-amino-transferase
- AMA:
-
Antimitochondrial antibodies
- ANA:
-
Antinuclear antibodies
- CI:
-
Confidence interval
- ELISA:
-
Enzyme-linked immunosorbent assay
- HCV:
-
Hepatitis C virus
- HIV:
-
Human immunodeficiency virus
- IFN:
-
Interferon
- L:
-
Litre
- LKM-1:
-
Liver kidney microsomal type 1 antibodies
- NA:
-
Not available
- ND:
-
Not detected
- NOSAs:
-
Non-organ-specific autoantibodies
- PCR:
-
Polymerase chain reaction
- RNA:
-
Ribonucleic acid
- SMA:
-
Antismooth muscle antibodies
- SVC:
-
Sustained viral clearance
- U:
-
Unit
References
Abdel-Hady M, Bunn SK, Sira J, Brown RM, Brundler MA, Davies P, Kelly DA (2011) Chronic hepatitis C in children — review of natural history at a National Centre. J Viral Hepat 18:e535–e540
Boccato S, Pistis R, Noventa F, Guido M, Benvegnù L, Alberti A (2006) Fibrosis progression in initially mild chronic hepatitis C. J Viral Hepat 13:297–302
Bortolotti F, Vajro P, Balli F, Giacchino R, Crivellaro C, Barbera C, Cataleta M, Muratori L, Pontisso P, Nebbia G, Zancan L, Bertolini A, Alberti A, Bianchi F (1996) Non-organ specific autoantibodies in children with chronic hepatitis C. J Hepatol 25:614–620
Bortolotti F, Verucchi G, Cammà C, Cabibbo G, Zancan L, Indolfi G, Giacchino R, Marcellini M, Marazzi MG, Barbera C, Maggiore G, Vajro P, Bartolacci S, Balli F, Maccabruni A, Guido M, Italian observatory for HCV infection and hepatitis C in children (2008) Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 134:1900–1907
Camarero C, Ramos N, Moreno A, Asensio A, Mateos ML, Roldan B (2008) Hepatitis C virus infection acquired in childhood. Eur J Pediatr 167:219–224
Carreño V, Bartolomé J, Castillo I, Quiroga JA (2012) New perspectives in occult hepatitis C virus infection. World J Gastroenterol 18:2887–2894
Cerutti F, Palomba E, Sacchetti C, Gay V, Versace A, Tovo PA (1999) Anti-HCV antibodies in a population of insulin-dependent diabetic children and adolescents. Diabetes Care 22:1587–1588
Conte D, Fraquelli M, Prati D, Colucci A, Minola E (2000) Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 31:751–755
European Paediatric Hepatitis C Virus Network (2005) Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis 41:45–51
Farmand S, Wirth S, Löffler H, Woltering T, Kenzel S, Lainka E, Henneke P (2012) Spontaneous clearance of hepatitis C virus in vertically infected children. Eur J Pediatr 171:253–258
Fitzpatrick E, Quaglia A, Vimalesvaran S, Basso MS, Dhawan A (2013) Transient elastography is a useful noninvasive tool for the evaluation of fibrosis in paediatric chronic liver disease. J Pediatr Gastroenterol Nutr 56:72–76
Gehring S, Kullmer U, Koeppelmann S, Gerner P, Wintermeyer P, Wirth S (2006) Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus infection treated with interferon-alpha. World J Gastroenterol 12:5787–5792
Goldschmidt I, Streckenbach C, Dingemann C, Pfister ED, di Nanni A, Zapf A, Baumann U (2013) Application and limitations of transient liver elastography in children. J Pediatr Gastroenterol Nutr 57:109–113
Gregorio GV, Pensati P, Iorio R, Vegnente A, Mieli-Vergani G, Vergani D (1998) Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 112:471–476
Indolfi G, Bartolini E, Olivito B, Azzari C, Resti M (2012) Autoimmunity and extrahepatic manifestations in treatment-naïve children with chronic hepatitis C virus infection. Clin Dev Immunol. doi:10.1155/2012/785627. Epub 2012 May 8
Jonas MM (2002) Children with hepatitis C. Hepatology 36(5 Suppl 1):S173–S178
Kelly D, Skidmore S (2002) Hepatitis C-Z: recent advances. Arch Dis Child 86:339–343
Lenzi M, Bellentani S, Saccoccio G, Muratori P, Masutti F, Muratori L, Cassani F, Bianchi FB, Tiribelli C (1999) Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case–control study of the Dionysos cohort. Gut 45:435–441
Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, Hoang C, Valla D, Piette JC (1994) Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106:1291–1300
Mast EE, Hwang LY, Seto DS, Nolte FS, Nainan OV, Wurtzel H, Alter MJ (2005) Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 192:1880–1889
Minola E, Prati D, Suter F, Maggiolo F, Caprioli F, Sonzogni A, Fraquelli M, Paggi S, Conte D (2002) Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood 99:4588–4591
Muratori P, Muratori L, Verucchi G, Attard L, Bianchi FB, Lenzi M (2003) Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis 37:1320–1326
Pembrey L, Newell M-L, Tovo P-A (2005) The management of HCV infected pregnant women and their children European paediatric HCV network. J Hepatol 43:515–525
Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J (2001) Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 34:730–739
Resti M, Jara P, Hierro L, Azzari C, Giacchino R, Zuin G, Zancan L, Pedditzi S, Bortolotti F (2003) Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol 70:373–377
Rumbo C, Fawaz RL, Emre SH, Suchy FJ, Kerkar N, Morotti RA, Shneider BL (2006) Hepatitis C in children: a quaternary referral center perspective. J Pediatr Gastroenterol Nutr 43:209–216
Ryder SD, Irving WL, Jones DA, Neal KR, Underwood JC (2004) Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 53:451–455
Seeff LB (2002) Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35–S46
Stroffolini T, Colloredo G, Gaeta GB, Sonzogni A, Angeletti S, Marignani M, Pasquale G, Venezia G, Craxì A, Almasio P (2004) Does an «autoimmune» profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey. J Viral Hepat 11:257–262
Sugden PB, Cameron B, Bull R, White PA, Lloyd AR (2012) Occult infection with hepatitis C virus: friend or foe? Immunol Cell Biol 90:763–773
Tovo P-A, Lazier L, Versace A (2005) Hepatitis B virus and hepatitis C virus infections in children. Curr Opin Infect Dis 18:261–266
Vogt M, Lang T, Frösner G, Klingler C, Sendl AF, Zeller A, Wiebecke B, Langer B, Meisner H, Hess J (1999) Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 341:866–870
Williams MJ, Lawson A, Neal KR, Ryder SD, Irving WL (2009) Autoantibodies in chronic hepatitis C virus infection and their association with disease profile. J Viral Hepat 16:325–331
Wong VS, Egner W, Elsey T, Brown D, Alexander GJ (1996) Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 104:25–31
World Health Organization (2002) Hepatitis C. Available at: http://www.who.int/csr/disease/hepatitis/Hepc.pdf. Accessed 07 Jan 2014.
Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (2007) Extrahepatic manifestations of hepatitis C virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis 39:2–17
Conflict of interest
The authors have no conflicts of interest to declare and no financial supports to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by David Nadal
Rights and permissions
About this article
Cite this article
Garazzino, S., Calitri, C., Versace, A. et al. Natural history of vertically acquired HCV infection and associated autoimmune phenomena. Eur J Pediatr 173, 1025–1031 (2014). https://doi.org/10.1007/s00431-014-2286-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-014-2286-6